首页> 外文期刊>Heart >Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions
【24h】

Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions

机译:人工瓣膜妊娠妇女的抗凝治疗:证据,指南和未回答的问题

获取原文
获取原文并翻译 | 示例
           

摘要

The management of women with mechanical heart valves during pregnancy remains difficult and controversial. There is no ideal anticoagulation regimen for this unique population, as there are inherent risks and benefits of each approach for both mother and fetus. There has been limited data available to guide the clinician in the optimal treatment strategy for an individual patient. The AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease created class recommendations for this population based upon current evidence, which is summarized in this review.
机译:在妊娠期间使用机械性心脏瓣膜的妇女的治疗仍然困难且存在争议。对于这种独特的人群,没有理想的抗凝方案,因为每种方法对母亲和胎儿都有固有的风险和益处。仅有有限的数据可用于指导临床医生针对单个患者的最佳治疗策略。 AHA / ACC瓣膜性心脏病患者治疗指南基于当前证据为该人群制定了分类建议,本综述对此进行了总结。

著录项

  • 来源
    《Heart》 |2015年第6期|430-435|共6页
  • 作者单位

    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA;

    Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号